AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2015
Feb 6, 2015
30718_dirs_2015-02-06_4015eb1b-5489-47bb-b8ba-df89b82dd894.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-02-05
Reporting Person: Dinarello Charles A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-05 | Common Stock | M | 1500 | $54.91 | Acquired | 5500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-05 | Stock Option | $54.91 | M | 1500 | Disposed | 2015-11-28 | Common Stock (1500) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $91.78 | 2024-10-29 | Common Stock (4000) | 4000 | Direct |
| Stock Option | $87.39 | 2023-10-30 | Common Stock (4000) | 4000 | Direct |
| Stock Option | $66.9 | 2022-10-24 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $70.35 | 2021-10-26 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $61.46 | 2020-10-27 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $63.03 | 2019-10-28 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $65.47 | 2018-10-22 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $66.59 | 2017-10-24 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $56.17 | 2016-10-25 | Common Stock (5000) | 5000 | Direct |
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4